SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-009676
Filing Date
2022-06-02
Accepted
2022-06-02 16:35:16
Documents
13
Period of Report
2022-06-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20220602x8k.htm   iXBRL 8-K 34207
2 EX-99.1 ampe-20220602xex99d1.htm EX-99.1 19983
  Complete submission text file 0001558370-22-009676.txt   179135

Data Files

Seq Description Document Type Size
3 EX-101.SCH ampe-20220602.xsd EX-101.SCH 3284
4 EX-101.LAB ampe-20220602_lab.xml EX-101.LAB 15365
5 EX-101.PRE ampe-20220602_pre.xml EX-101.PRE 10380
7 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20220602x8k_htm.xml XML 4630
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 22991338
SIC: 2834 Pharmaceutical Preparations